Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics sets virtual 2026 annual meeting for September 10, 2026

Neutral Impact 2 of 5 shareholder Written later

Polaryx Therapeutics' board set its 2026 Annual Meeting of Stockholders to be held virtually on September 10, 2026, with a July 27, 2026 record date. The filing also sets a July 27, 2026 deadline for stockholder proposals and director nominations to be considered for the proxy materials, because the company held no annual meeting in 2025.

Key points

  • Annual Meeting to be held virtually on September 10, 2026
  • Stockholders of record at close of business on July 27, 2026 may vote
  • Deadline for stockholder proposals and director nominations for proxy inclusion is close of business on July 27, 2026
  • Company may change the record date, meeting date and location before the meeting

The filing

CompanyPolaryx Therapeutics, Inc. (PLYX)
Form8-K, current report
Filed with the SECJul 17, 2026, 8:00 AM ET
Accession number0001213900-26-078912

Items reported: 5.08 Shareholder Director Nominations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.